Skip to content
healthcare.dev

Zegerid OTC

NDC 82632-699, omepraole, sodium bicarbonate, capsule, gelatin coated, from Riley Consumer Care LLC.

Product NDC
82632-699
Status
Listed
Labeler
Riley Consumer Care LLC
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA201361
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82632-699 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMEPRAZOLE20 mg/1
  • SODIUM BICARBONATE1100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
82632-699-01826320699011 BOTTLE in 1 CARTON (82632-699-01) / 14 CAPSULE, GELATIN COATED in 1 BOTTLE
82632-699-03826320699033 BOTTLE in 1 CARTON (82632-699-03) / 14 CAPSULE, GELATIN COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82632-699 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82632-699 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82632-699. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.